Glibenclamide 2.5mg Tablets BP

Country: United Kingdom

Bahasa: Inggeris

Sumber: myHealthbox

Bahan aktif:

Glibenclamide

Boleh didapati daripada:

Aurobindo Pharma Limited

Kod ATC:

A10BB01

INN (Nama Antarabangsa):

Glibenclamide

Dos:

2.5mg

Borang farmaseutikal:

Tablets

Laluan pentadbiran:

Oral use

Unit dalam pakej:

100, 500 or 1000 tablets

Jenis preskripsi:

POM - Prescription Only Medicine

Dikeluarkan oleh:

Aurobindo Pharma Limited

Kumpulan terapeutik:

Sulfonamides, Urea derivatives

Tanda-tanda terapeutik:

It is a hypoglycaemic agent indicated in the treatment of non-insulin dependent diabetes in patients who respond inadequately to dietary measures alone.

Status kebenaran:

Authorised

Tarikh kebenaran:

2009-02-20

Risalah maklumat

1
PACKAGE LEAFLET: INFORMATION FOR THE USER
GLIBENCLAMIDE 2.5MG TABLETS
GLIBENCLAMIDE 5MG TABLETS
(Glibenclamide)
Please tell your doctor or pharmacist if you are taking or have
recently taken any
other medicines, including medicines obtained without a prescription.
The dose of Glibenclamide may need to be reduced if you are taking the
following:
• drugs which are used to treat infections e.g. _fluconazole,
sulphonamides_
• pain killers e.g. aspirin, phenylbutazone
• blood thinning agents e.g. _heparin_
• cholesterol lowering agents e.g._ clofibrate_
• anti-depressants e.g. _MAOIs, nortriptyline_
• drugs for high blood pressure and heart failure
e.g. _captopril,_ _enalapril_
• medicines for stomach ulcers and dyspepsia e.g. _cimetidine,
ranitidine_
• drugs for obesity and gout
The dose of Glibenclamide may need to be increased if you are taking
the
following:
• rifampicin.
• tablets for getting rid of water in the body.
• drugs for high blood pressure and heart trouble.
• some products purchased at the chemists may have a high sugar
content
which may raise blood sugar levels.
TAKING GLIBENCLAMIDE TABLETS WITH FOOD AND DRINK:
Glibenclamide should be taken with or immediately after food.
Alcohol may cause flushes in some patients and can affect the levels
of sugar in
your blood.
PREGNANCY AND BREAST-FEEDING
Tell your doctor if you are pregnant, planning to become pregnant or
breast-
feeding.
Do not breastfeed whilst on Glibenclamide Tablets without advice from
your
doctor.
EFFECTS ON THE ABILITY TO DRIVE AND USE MACHINES:
If you experience the symptoms of low blood sugar (hypoglycaemia) you
should
not drive or operate machinery.  Low blood sugar may occur at the
beginning of
treatment while your doctor is trying to find the dose that bests
suits you. Your
doctor will give you further advice. When your blood sugar is
stabilized you may
drive or operate machinery.
IMPORTANT INFORMATION ABOUT SOME OF THE INGREDIENTS OF GLIBENCLAMIDE
TABLETS
These tablets contain lacto

Ciri produk

Glibenclamide Aurobindo 2.5mg tablets
Summary of Product Characteristics Updated 24­Aug­2015 | Aurobindo Pharma ­ Milpharm Ltd.
1. Name of the medicinal product
Glibenclamide 2.5mg Tablets BP,
Liamid 2.5mg Tablets,
Gliken 2.5mg Tablets
2. Qualitative and quantitative composition
Each tablet contains Glibenclamide 2.5mg.
For a full list of excipients, see section 6.1.
3. Pharmaceutical form
Tablet for oral use
Glibenclamide 2.5mg Tablets are white, circular tablets marked 'GL 2.5' on one face and plain on the reverse.
4. Clinical particulars
4.1 Therapeutic indications
Glibenclamide is a hypoglycaemic agent indicated in the treatment of non­insulin dependent diabetes in patients who
respond inadequately to dietary measures alone.
4.2 Posology and method of administration
_For oral administration._
_Treatment of previously untreated diabetes:_
Stabilisation can be started with one 5mg tablet daily with or immediately after breakfast or the first main meal. If
control is satisfactory one tablet is continued as the maintenance dose. If control is unsatisfactory, the dose can be
adjusted by increments of 2.5 or 5mg at weekly intervals. The total daily dosage rarely exceeds 15mg and increasing
the daily dosage above this does not generally produce any additional effect.
The total daily requirement should normally be given as a single dose at breakfast, or with the first main meal. The
patient's diet and activity should be taken into account.
Children: Glibenclamide is not recommended for use in children.
Elderly: In debilitated patients or aged patients who may be more liable to hypoglycaemia, treatment should be initiated
with one 2.5mg tablet daily.
_Changeover from other sulphonylureas:_
The changeover to glibenclamide from other drugs with similar mode of action can be carried